Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 1
Author(s): S. Boehm
Affiliation:
Export Options
About this article
Cite this article as:
Boehm S., Meet Our Editorial Board Member, Current Neuropharmacology 2020; 18 (1) . https://dx.doi.org/10.2174/1570159X1801191216143152
DOI https://dx.doi.org/10.2174/1570159X1801191216143152 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
23
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Bioaccessibility of Bioactive Compounds and Prebiotic Properties of Fruit and Vegetable By-products - A Mini Review
Current Bioactive Compounds Synthesis of Magnetite Nanoparticles Under UV/IR Irradiation: Investigation of Effects on the Properties
Nanoscience & Nanotechnology-Asia Recent Pharmacoproteomics Studies of Warfarin in the Asia-Pacific: A New Strategy for Personalized Medicine?
Current Pharmacogenomics and Personalized Medicine Glucocorticoid Regulates Parkin Expression in Mouse Frontal Cortex: Implications in Schizophrenia
Current Neuropharmacology Trigeminal Neuralgia: Basic and Clinical Aspects
Current Neuropharmacology Modelling Anxiety in Humans for Drug Development
Current Neuropharmacology Quorum-Sensing Inhibitors and Biofilms
Anti-Infective Agents in Medicinal Chemistry Marking the Centennial of Alzheimers First Report of the Disease with a Perspective of Ongoing Research and Future Challenge
Current Alzheimer Research Association between the Regulator of G-protein Signaling 9 Gene and Patients with Methamphetamine Use Disorder and Schizophrenia
Current Neuropharmacology <i>In Silico</i> Study Examining New Phenylpropanoids Targets with Antidepressant Activity
Current Drug Targets Role of the Central Cholinergic System in the Therapeutics of Schizophrenia
Current Neuropharmacology Dopamine Pharmacological Agents in Resistant-OCD
Current Psychopharmacology Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry N-Phenylamine Derivatives as Aggregation Inhibitors in Cell Models of Tauopathy
Current Alzheimer Research Phytol a Natural Diterpenoid with Pharmacological Applications on Central Nervous System: A Review
Recent Patents on Biotechnology Overview and Findings from the Religious Orders Study
Current Alzheimer Research 3D Pharmacophore Based Virtual Screening of A2A Adenosine Receptor Antagonists
Protein & Peptide Letters Neuropeptides as Therapeutic Approach to Autoimmune Diseases
Current Pharmaceutical Design Analysis of Genetic Polymorphisms in Acetylcholinesterase as Reflected in Different Populations
Current Alzheimer Research Pharmacologic Treatments in “Prodromal Psychosis:” Making Clinical Decisions in the Absence of a Consensus
Adolescent Psychiatry